CORONARY ARTERY DISEASE AND CARDIOVASCULAR OUTCOMES IN HEART FAILURE: INSIGHTS FROM THE VERICIGUAT GLOBAL STUDY IN SUBJECTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION (VICTORIA) TRIAL

MLA

Carolyn S.P. Lam, et al. “Coronary Artery Disease and Cardiovascular Outcomes in Heart Failure: Insights from the Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction (Victoria) Trial.” Journal of the American College of Cardiology, vol. 77, May 2021, p. 141. EBSCOhost, https://doi.org/10.1016/s0735-1097(21)01500-x.

APA

Carolyn S.P. Lam, Amanda Stebbins, Adrian F. Hernandez, Paul W. Armstrong, Dan Atar, Adriaan A. Voors, Lothar Roessig, Imran Zainal Abidin, Javed Butler, Kevin J. Anstrom, Burkert Pieske, Christopher M. O’Connor, Basil S. Lewis, Clara Ines Saldarriaga Giraldo, Justin A. Ezekowitz, Joerg Koglin, & Piotr Ponikowski. (2021). Coronary Artery Disease and Cardiovascular Outcomes in Heart Failure: Insights from the Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction (Victoria) Trial. Journal of the American College of Cardiology, 77, 141. https://doi.org/10.1016/s0735-1097(21)01500-x

Chicago

Carolyn S.P. Lam, Amanda Stebbins, Adrian F. Hernandez, Paul W. Armstrong, Dan Atar, Adriaan A. Voors, Lothar Roessig, et al. 2021. “Coronary Artery Disease and Cardiovascular Outcomes in Heart Failure: Insights from the Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction (Victoria) Trial.” Journal of the American College of Cardiology 77 (May): 141. doi:10.1016/s0735-1097(21)01500-x.